Home » Newsletters » BioWorld Asia

BioWorld Asia

July 19, 2000

View Archived Issues

Drugs For Sleep Disorders Could Follow Circadian Rhythm Finding

Zeltia Share Issue Brings In $172M On Madrid Exchange

EU Commissioners Determined To Resolve Biotech Standstill

Alizyme Plans To Raise #21M Through Public, Private Means

Other News To Note

Genomatix Completes First Pass At Promoter Sequence Analysis

French Government Launches Fund To Help Biotech Start-Ups

KS Biomedix Taking Sheep Antibody Into Human Trials

Transgene Selects 2 HGS Genes For Cardiovascular Applications

RiboTargets Gets Boost With #6M Second-Round Financing

Xenova Raises #10M In Units Offering In 'Improving' Market

French Government Confirms Its Stand On Gene Patenting

Challenges Pending For New Biotechnology Patent Rules

Biovector Plans To Move Flu Vaccine Into Phase III Trials

IBT Forced To Restructure Due To Shareholder Pressure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...